Sodium Hydroxide → 4-[4-[4-(4-Pyridyl)piperazin-1-yl]phenoxy]butyric acid

HRID 2209

Reaktionsgleichung

Reaktionsgleichung von HRID 2209
[N:1]1[CH:6]=[CH:5][C:4]([N:7]2[CH2:12][CH2:11][N:10]([C:13]3[CH:18]=[CH:17][C:16]([OH:19])=[CH:15][CH:14]=3)[CH2:9][CH2:8]2)=[CH:3][CH:2]=1.[OH-:20].[Na+]>C(O)C>[N:1]1[CH:6]=[CH:5][C:4]([N:7]2[CH2:8][CH2:9][N:10]([C:13]3[CH:18]=[CH:17][C:16]([O:19][CH2:13][CH2:14][CH2:15][C:16]([OH:19])=[O:20])=[CH:15][CH:14]=3)[CH2:11][CH2:12]2)=[CH:3][CH:2]=1

Komponenten

4

Versuchsvorschrift

A solution of the product of Example 25 (0.1 g) in aqueous sodium hydroxide (1N, 0.8 ml) and ethanol (2 ml) was kept for 2 hours. The solution was evaporated and the residue dissolved in water (5 ml). Hydrochloric acid (1N, 0.8 ml) was added and the precipitate was filtered and washed with water and ether to give the title compound as a solid: m.p 305°-306° C.; m/e 342(M+H)+ ; NMR(d6DMSO) δ 8.0(2H,d); 6.72(6H,m); 3.74(2H,t); 3.3(4H,m); 2.94(4H,m); 2.19(2H,t); 1.72(2H, m); calculated for C19H23N3O3 : C, 66.8; H, 6.8; N, 12.3. Found: C, 67.0; H, 6.8; N, 12.2%.

Aufarbeitung

  1. customThe solution was evaporated
  2. dissolutionthe residue dissolved in water (5 ml)
  3. additionHydrochloric acid (1N, 0.8 ml) was added
  4. filtrationthe precipitate was filtered
  5. washwashed with water and ether

Quellen und Nachweise

ORD-Eintrag
ord-f32c2189fde44a52a00908f735c49175
Quelldatensatz
uspto-grants-1998_03
Patentnummer
US05728701

Verknüpfte Notizen

Wird geladen…